Trials / Conditions / MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)

9 registered clinical trials studyying MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis) — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Pop NCT07330830	Centre Hospitalier Universitaire de la Guadeloupe	—
Recruiting	The Development of MASLD Among Survivors of Breast or Colorectal Cancer NCT07280143	University of Bern	—
Enrolling By Invitation	Assessment of Non-Invasive Testing in Major Liver-Related Outcomes NCT06986447	HRI-MAIL-NIT	—
Recruiting	Thermoacoustic Method for Estimating Liver Fat Fraction NCT07321925	Endra Lifesciences	—
Not Yet Recruiting	Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography a NCT07025980	Eva Cubric	Phase 2
Not Yet Recruiting	Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study) NCT06907563	Universität des Saarlandes	—
Recruiting	Digital Early Warning System for Acute Lung Injury in Liver Surgery NCT07070362	Beijing Tsinghua Chang Gung Hospital	—
Completed	Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Compli NCT07389122	University of Bologna	—
Completed	Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) NCT03938246	Sagimet Biosciences Inc.	Phase 2